Life Biosciences Announces First-in-Human Data from Ongoing Phase 1 Trial Evaluating ER-100 in Optic Neuropathies

BOSTON, Oct. 08, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=JYzmqkrsbOenaAmConedhLsuUUcz_07520rg3pvjbBPJsOfhKicoqNR4IkfylbuwktsbYbRnjQUBbbFxuNGaZ-zY7HPlRHMeDCEgLTMjIzQ=" rel="nofollow"...